- Report
- February 2024
- 93 Pages
Global
From €3500EUR$3,901USD£3,106GBP
- Drug Pipelines
- July 2018
- 616 Pages
Global
From €21145EUR$22,000USD£18,133GBP
- Report
- March 2022
Global
From €4662EUR$4,850USD£3,997GBP
- Report
- March 2021
Japan, United States, ... Japan, United States, Europe
From €913EUR$950USD£783GBP
- Report
- February 2020
Japan, United States, ... Japan, United States, Europe
From €913EUR$950USD£783GBP
- Report
- April 2023
- 263 Pages
Global
From €5507EUR$5,730USD£4,723GBP
- Report
- June 2022
- 230 Pages
Global
From €5545EUR$5,769USD£4,755GBP
- Report
- January 2022
- 220 Pages
Global
From €5928EUR$6,168USD£5,084GBP
- Report
- April 2023
- 160 Pages
Global
From €5766EUR$5,999USD£4,945GBP
- Report
- April 2023
- 160 Pages
Global
From €5766EUR$5,999USD£4,945GBP
- Report
- May 2023
- 160 Pages
Global
From €5766EUR$5,999USD£4,945GBP
Methotrexate is a drug used to treat immune disorders, such as rheumatoid arthritis, psoriasis, and Crohn's disease. It works by blocking the action of an enzyme involved in the production of certain proteins that are necessary for the growth and development of cells. It is also used to treat certain types of cancer. Methotrexate is available in both oral and injectable forms.
Methotrexate is a widely used drug in the treatment of immune disorders. It is generally well tolerated and has been shown to be effective in reducing symptoms and improving quality of life. It is also used in combination with other drugs to treat more severe cases of immune disorders.
The market for Methotrexate is highly competitive, with many companies offering different formulations of the drug. Some of the major players in the market include Pfizer, Merck, Novartis, and AbbVie. Show Less Read more
